EMpagliflozin to PREvent worSening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction
Clinical trial NCT05020704 · UNKNOWN
Trial details
- NCT number
- NCT05020704
- Sponsor
- NHS Greater Glasgow and Clyde
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-16
- Primary completion
- 2024-06-12
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.